top of page
Search

SLE Manifestations & Autoantibodies — MRCP Part 1

TL;DR

For MRCP Part 1, systemic lupus erythematosus (SLE) is tested through clinical patterns and antibody associations rather than memorised criteria. You must link manifestations (renal, haematological, cutaneous, obstetric) to key antibodies such as anti-dsDNA, anti-Sm and antiphospholipid antibodies. This guide distils high-yield associations, common traps, and an SBA-style case to sharpen exam technique.


Why this matters

SLE is a high-frequency topic in MRCP Part 1 because it integrates immunology, nephrology, rheumatology, haematology and obstetrics. Examiners often present subtle laboratory clues rather than explicit diagnostic criteria. Recognising patterns—such as rising anti-dsDNA with falling complement or prolonged APTT in a thrombosis scenario—distinguishes strong candidates from average ones.

If you are structuring your revision, begin with the MRCP Part 1 overview and consolidate knowledge with Free MRCP MCQs after reading this article.

Authoritative references include:


Core Clinical Domains in SLE

For MRCP Part 1, focus on five recurring domains:

  1. Cutaneous and mucosal manifestations

  2. Renal involvement (lupus nephritis)

  3. Neuropsychiatric lupus

  4. Haematological abnormalities

  5. Autoantibodies and complement interpretation


High-Yield Manifestations & Antibodies (Exam Table)

Domain

Clinical Clues

Key Antibodies

MRCP Pearl

Cutaneous

Malar rash, photosensitivity, oral ulcers

ANA, anti-Ro

Anti-Ro linked to subacute cutaneous lupus

Musculoskeletal

Non-erosive inflammatory arthritis

ANA

Unlike RA, typically non-erosive

Renal

Proteinuria, RBC casts

Anti-dsDNA, low C3/C4

dsDNA titres correlate with nephritis

Neuropsychiatric

Seizures, psychosis

Antiphospholipid Abs

Consider thrombotic mechanism

Haematological

Cytopenias, Coombs-positive haemolysis

Anti-dsDNA

Autoimmune haemolysis may occur

Obstetric

Recurrent miscarriage

Lupus anticoagulant

Prolonged APTT but thrombosis risk ↑

The 5 Most Tested Subtopics

1. Anti-dsDNA and Disease Activity

  • Highly specific for SLE

  • Correlates with disease activity

  • Rising titres + low complement → flare, especially nephritis

Exam insight: Complement consumption (C3, C4) signals immune complex activity.

2. Anti-Sm Antibody

  • Highly specific, low sensitivity

  • Does not correlate with activity

  • Strong diagnostic marker in exam questions

3. Anti-Ro (SSA) and Anti-La (SSB)

Associated with:

  • Subacute cutaneous lupus

  • Neonatal lupus

  • Congenital heart block

In pregnancy scenarios, anti-Ro is frequently tested.

4. Antiphospholipid Antibodies

Includes:

  • Lupus anticoagulant

  • Anticardiolipin

  • Anti-β2 glycoprotein I

Classic MRCP pattern:Prolonged APTT + thrombosis or recurrent miscarriage.

5. Complement Levels

  • Low C3/C4 = active immune complex disease

  • Falling complement may precede clinical flare

  • CRP often normal unless infection is present

MRCP Part 1 candidate revising rheumatology notes and practising MCQs on systemic lupus erythematosus.”

Mini-Case (Single Best Answer)

A 26-year-old woman presents with photosensitive rash and arthralgia. Urinalysis shows 3+ protein and RBC casts. Blood tests reveal raised anti-dsDNA titres and low C3.

What is the most likely underlying renal mechanism?

A. Mesangial IgA depositionB. Immune complex deposition in glomeruliC. ANCA-mediated vasculitisD. Anti-GBM antibody disease

Answer: B. Immune complex deposition in glomeruli

Explanation: Lupus nephritis results from circulating immune complex deposition in glomerular structures. Rising anti-dsDNA and low complement support active immune complex-mediated inflammation.

Reinforce this pattern recognition using the Free MRCP MCQs or simulate exam pressure with a timed paper — Start a mock test.


5 Common MRCP Traps

  1. ANA positivity alone does not confirm SLE Low-titre ANA occurs in healthy individuals.

  2. Prolonged APTT does not mean bleeding risk in APS It reflects laboratory interference, not anticoagulation.

  3. Markedly raised CRP suggests infection, not flare

  4. Lupus arthritis is non-erosive Erosions suggest rheumatoid arthritis.

  5. Complement interpretation matters Normal complement reduces likelihood of active immune complex nephritis.


Practical Study Checklist

Before exam day, ensure you can:

  • ☐ Link anti-dsDNA to nephritis and complement consumption

  • ☐ Recognise antiphospholipid syndrome patterns

  • ☐ Distinguish lupus arthritis from RA

  • ☐ Interpret ESR vs CRP differences

  • ☐ Identify pregnancy risks associated with anti-Ro

For structured revision planning, see our recommended Study plan for MRCP Part 1 and integrate SLE with connective tissue disease topics in your lecture schedule.


FAQs

1. Which antibody is most specific for SLE?

Anti-Sm is highly specific but less sensitive. Anti-dsDNA is also specific and more clinically useful for monitoring activity.

2. Do anti-dsDNA titres reflect disease severity?

Yes. Rising titres and falling complement often indicate active lupus, particularly nephritis.

3. Why is APTT prolonged in antiphospholipid syndrome?

Lupus anticoagulant interferes with phospholipid-dependent clotting assays in vitro, prolonging APTT despite increased thrombosis risk.

4. How is lupus arthritis different from RA?

Lupus arthritis is usually non-erosive and less deforming compared to rheumatoid arthritis.

5. Is ANA mandatory for diagnosis?

ANA is highly sensitive and present in most patients, but diagnosis relies on combined clinical and immunological criteria.


Ready to start?

SLE rewards pattern recognition over memorisation. Strengthen your exam readiness with our Free MRCP MCQs and simulate real exam conditions — Start a mock test. For comprehensive system-based coverage, revisit the MRCP Part 1 overview.


Sources

 
 
 

Comments

bottom of page